Cerity Partners LLC Acquires 30,093 Shares of Veeva Systems Inc. $VEEV

Cerity Partners LLC raised its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 29.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 132,624 shares of the technology company’s stock after buying an additional 30,093 shares during the period. Cerity Partners LLC’s holdings in Veeva Systems were worth $39,510,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. CoreCap Advisors LLC boosted its holdings in Veeva Systems by 257.3% during the 3rd quarter. CoreCap Advisors LLC now owns 1,297 shares of the technology company’s stock valued at $386,000 after acquiring an additional 934 shares during the period. Greenleaf Trust purchased a new position in Veeva Systems in the 3rd quarter worth approximately $222,000. Gries Financial LLC lifted its position in Veeva Systems by 7.1% in the third quarter. Gries Financial LLC now owns 782 shares of the technology company’s stock valued at $233,000 after purchasing an additional 52 shares during the last quarter. Chicago Capital LLC boosted its stake in shares of Veeva Systems by 0.3% during the third quarter. Chicago Capital LLC now owns 284,338 shares of the technology company’s stock valued at $84,707,000 after purchasing an additional 786 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of Veeva Systems by 6.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 801,367 shares of the technology company’s stock valued at $238,735,000 after purchasing an additional 51,949 shares during the period. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Key Stories Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva and BioMarin announced a long‑term strategic partnership to accelerate development and commercialization workflows — strengthens a customer relationship with recurring revenue and cross‑sell potential. Veeva and BioMarin Form Long-Term Strategic Partnership
• Positive Sentiment: Veeva launched an Environmental Monitoring solution to modernize quality‑control in manufacturing — expands Veeva’s manufacturing QC portfolio and creates new upsell opportunities to regulated customers. Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
• Positive Sentiment: Novo Nordisk’s International Operations committed to Veeva Vault CRM — a significant commercial win that validates Veeva’s CRM and agentic AI positioning and can drive multi‑year recurring revenue. Novo Nordisk International Operations Commits to Veeva Vault CRM
• Positive Sentiment: The board authorized up to $2 billion to repurchase Class A shares — a sizable buyback that should support EPS and reduce float, typically viewed positively by investors. Veeva authorized to purchase up to $2B of shares of Class A stock
• Positive Sentiment: Analyst sentiment improved — Truist upgraded VEEV from hold to buy, and Stifel Nicolaus also published a buy — upgrades can lift demand and broker coverage. Veeva Systems (VEEV) Gets a Buy from Stifel Nicolaus
• Neutral Sentiment: Veeva will present at the J.P. Morgan 2026 Healthcare Conference — useful for investor visibility but not an immediate fundamental change. Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
• Neutral Sentiment: Multiple press stories noted the stock is trading up — reflects market reaction to the combination of the above items rather than new company fundamentals. Veeva Systems (VEEV) stock trades up, here is why

Analyst Ratings Changes

Several brokerages recently commented on VEEV. Needham & Company LLC reiterated a “buy” rating and set a $355.00 price target on shares of Veeva Systems in a report on Friday, November 21st. Truist Financial upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a research report on Thursday. Canaccord Genuity Group reaffirmed a “buy” rating on shares of Veeva Systems in a research note on Tuesday, November 25th. Wall Street Zen cut Veeva Systems from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Finally, Citigroup reduced their price target on Veeva Systems from $349.00 to $319.00 and set a “buy” rating on the stock in a report on Monday, November 24th. Nineteen equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $307.42.

Veeva Systems Stock Performance

Shares of NYSE VEEV opened at $241.31 on Friday. The company has a 50 day simple moving average of $247.98 and a two-hundred day simple moving average of $271.38. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The company has a market capitalization of $39.67 billion, a price-to-earnings ratio of 46.95, a P/E/G ratio of 1.77 and a beta of 1.07.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company had revenue of $0.81 million for the quarter, compared to the consensus estimate of $792.37 million. During the same quarter in the prior year, the business posted $1.75 EPS. The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. On average, analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Veeva Systems announced that its Board of Directors has approved a stock buyback plan on Monday, January 5th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the technology company to purchase up to 5.5% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board believes its stock is undervalued.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.